...BRCA2 genes confer a high risk of breast and ovarian cancer but the incomplete penetrance of these mutations suggests th...
...BRCA2 gene (HR = 3.50; 95% CI 1.25-9.78; P = 0.017).,Our results confirm that AIB1 poly-Q repeat length polymorphism doe...
Germ-line mutations in the tumour suppressor proteins BRCA1 and BRCA2 predispose to breast and ovarian cancer. We have r...
...BRCA2 as well as BRCA1 carriers. A few studies have also investigated the genetic contribution of RAD51 135G>C to the ri...
...BRCA2 gene. To determine the impact of BRCA1 and BRCA2 LGRs in South Africa, 52 hereditary breast and/or ovarian South A...
...BRCA2 and CHEK2 from the literature, was used to simulate the familial clustering of breast cancer under different scena...
...BRCA2. Since this topic could also become relevant for other gene-related diseases, society as a whole has to consider t...
...BRCA2 mutations using a case-only study design. Breast cancer cases that had been tested for BRCA1 and BRCA2 mutations w...
...BRCA2 (BRCA1/2) test result acceptors and decliners.,Randomized trial of genetic counseling conducted from February 2003...
...BRCA2 and non-BRCA1/2 breast tumours by gene expression profiling and found that 74% BRCA1 tumours were basal-like, 73% ...
Contact
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
WeChat Official Account
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com
Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2
